Propylthiouracil vasculitis. case report
DOI:
https://doi.org/10.51481/amc.v44i2.412Keywords:
Propitiouracilo, vasculitis, autoanticuerpos citoplasmáticos anti-neutrófiloAbstract
We report a case of 43-year-old woman who developed two complications associated with the use of propylthiouracil: vasculitis and agranulocytosis. Vasculitis associated with antithyroid therapy is a rare well- documented clinical entity with a pathogenic mechanism not clear yet. There a few published reports of an association between treatment with propylthiouracil, and the occurrence of ANCA positivity and ANCA-associated vasculitis. This is probably one moreDownloads
References
Greenspan F, Dong B. Medicamentos tiroideos y antitiroideos. En:Katzung B, ed. Farmacología Básica y Clínica. México: ManualModerno, 1991:472-78.
Harper L, Cockwell P, Savage C. Case of propylthiouracil-inducedANCA associated small vessel vasculitis. Nephrol Dial Transplant.1998; 13(2): 455-8.
Dolman KM, Gans RO, Vervaat TJ, Zevenbergen G, et al. Vasculitisand antineutrophil cytoplasmatic autoantibodies associatedwithpropylthiouracil therapy. Lancet. 1993; 342:651-2.
Choi HK, Merckel PA, Niles JL. Drug-associated antineutrophilcytoplasmaticautoantibody-positivevasculitis: prevalence amongpatients with high titers of antimyloperoxidase antibodies. ArthritisRheum. 2000; 43 (2): 405-413.
Chastain M, Russo G, Boh E, et al. Propylthiouracil hypersensitivity:Report of two patients with vasculitis and review of the literature. J AmAcad Dermatol 1999; 41:757-64.
Dhillon S, Singh D, Doe N, et al. Diffuse alveolar hemorrhage andpulmonary capillaritis due propylthiouracil. Chest. 1999; 11 6 ( 5 ) : 1 4 8 5 - 8
.Stankus S, Johnson N. Propylthiouracil- induced hypersensitivityvasculitis presenting as respiratory failure. Chest. 1992; 102 (5): 1595-6.
Carrasco M, Riera C, Clotet B, et al. Cutaneous vasculitis associatedwith propylthiouracil therapy. Arch Intern Med. 1987; 147(9):1677.
Vasily D, Tyler W. Propylthiouracil- induced cutaneous vasculitis.Casepresentationandreview of the literature. JAMA. 1980;243(5):458-61.
Houston B, Crouch M. Brick J, DiBartolomeo A. Apparent vasculitisassociated with propylthiouracil use. Arthritis Rheum. 1979; 22(8):925-8.
Gunton JE. Prevalence of positive anti-neutrophil cytoplasmaticantibody (ANCA) in patients receiving anti-thyroid medication. EurJ.Endocrinol 2000 ; 142(6):587.
Sato H. High prevalence of antineutrophil cytoplasmic antibodypositivity in childhoodonset Graves'diseasetreatedwithpropylthiouracil. J Clin Endocrinol Metab 2000; 85(11): 4270-3.
Morita S, Ueda Y, Eguchi K. Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature. EndocrJ. 2000; 47(4): 467-70. (Abstract).Vasculitis por Propiltiouracilo/ Salas D et al
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
